Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
Journal Title: UNKNOWN - Year 2017, Vol 23, Issue 4
Abstract
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system and is characterized by inflammation, demyelination, and axonal loss. Fingolimod is the first oral drug for the treatment of MS approved by the United States Food and Drug Administration, European Union countries, and various other countries. The compound exerts its effect via interaction with lysophospholipid receptors known as sphingosine-1 phosphate receptors. Although fingolimod has a very convenient daily oral dosing, it may cause development of bradycardia at the first dose, macular edema, infection, all of which require attention. Randomized double-blind clinical trials have shown that fingolimod significantly reduces relapse rates and is beneficial in brain magnetic resonance imaging measures when compared with both placebo and intramuscular interferon β-1a. This review describes the characteristics of fingolimod concerning its efficacy, safety, and tolerability in the clinical context of the management of MS.
Authors and Affiliations
Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir
Keywords
Related Articles
- EP ID EP276790
- DOI 10.4274/tnd.62144
- Views 81
- Downloads 0
Aortic Dissection Presenting with Transient Paraplegia
.
Isolated Third, Fourth, and Sixth Cranial Nerve Palsies in the Turkish Population: Etiologic Factors and Clinical Course
Objective: To determine the etiologic factors and clinical profile of isolated third, fourth, and sixth nerve palsies in neuro-ophthalmology outpatient clinics of two different reference centers. Materials and Methods:...
Cerebral Palsy and Genetics
.
Comparison of the Original and Parallel Forms of the Three Words-Three Shapes Test
Objective: The Three Words-Three Shapes test is a moderately difficult memory and learning test, which is very suitable for use in clinical applications. It allows the evaluation of both verbal and non-verbal materials i...
Evaluation of Seizure After Stroke in Stroke Unit
Objective: Patients with stroke may experience epileptic seizures as acute phase (usually defined as the first 15 days) or late phase complications. Risk factors are young age, male sex, cortical involvement and hemorrha...